The PE Ratio as of September 2024 (TTM) for CollPlant Biotechnologies Ltd. (CLGN) is -3.35

According to CollPlant Biotechnologies Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is -3.35. This represents a change of -7.80% compared to the average of -3.63 of the last 4 quarters.

CollPlant Biotechnologies Ltd. (CLGN) Historical PE Ratio (quarterly & annually)

How has CLGN PE Ratio performed in the past?

The mean historical PE Ratio of CollPlant Biotechnologies Ltd. over the last ten years is 35.13. The current -3.35 PE Ratio has changed -1053.71% with respect to the historical average. Over the past ten years (40 quarters), CLGN's PE Ratio was at its highest in in the September 2020 quarter at 20.65. The PE Ratio was at its lowest in in the June 2021 quarter at -17.81.

CollPlant Biotechnologies Ltd. (CLGN) PE Ratio by Quarter and Year

Discovering the peaks and valleys of CollPlant Biotechnologies Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

CollPlant Biotechnologies Ltd. (CLGN) Average PE Ratio

How has CLGN PE Ratio performed in the past?

The current PE Ratio of CollPlant Biotechnologies Ltd. (CLGN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

CollPlant Biotechnologies Ltd. (CLGN) PE Ratio vs. Peers

How is CLGN’s PE Ratio compared to its peers?

CollPlant Biotechnologies Ltd.’s PE Ratio is greater than Keros Therapeutics, Inc. (-11.28), greater than Merus N.V. (-18.45), less than Vericel Corporation (2.79K), less than Century Therapeutics, Inc. (-0.91), less than Shattuck Labs, Inc. (-2.08), greater than C4 Therapeutics, Inc. (-3.44), greater than Eliem Therapeutics, Inc. (-3.49), less than Prelude Therapeutics Incorporated (-2.83), less than Monte Rosa Therapeutics, Inc. (-3.11), less than Molecular Partners AG (-2.67), greater than MediciNova, Inc. (-12.61), greater than Anebulo Pharmaceuticals, Inc. (-4.99), greater than Champions Oncology, Inc. (-7.94), greater than Cyteir Therapeutics, Inc. (-3.52), less than Replimune Group, Inc. (-3.26), greater than Crinetics Pharmaceuticals, Inc. (-15.40), greater than NewAmsterdam Pharma Company N.V. (-7.25), greater than PureTech Health plc (-4.31), less than Ikena Oncology, Inc. (-1.22), less than Enochian Biosciences, Inc. (-1.24), less than HCW Biologics Inc. (-0.69), less than Exicure, Inc. (-1.84),

Build a custom stock screener for CollPlant Biotechnologies Ltd. (CLGN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CollPlant Biotechnologies Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

CollPlant Biotechnologies Ltd. (CLGN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like CollPlant Biotechnologies Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.